Matches in SemOpenAlex for { <https://semopenalex.org/work/W3031081258> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W3031081258 endingPage "281" @default.
- W3031081258 startingPage "278" @default.
- W3031081258 abstract "Objective To investigate the long-term efficacy and complications of brachytherapy in early stage prostate cancer.Methods The data of 117 cases of early stage prostate cancer patients were analyzed,aged from 51 to 84 years,with an average of 73 years.The PSA ranged from 0.4 to 47.6 μg/L (14.7 in average),Gleason score ranged from 4 to 9 (6.4 in average),clinical stage ranged from T1b to T2c,the prostate volume ranged from 13 to 69 ml (31 ml in average),and the positive biopsy rate was 8％to 100％ (45％ in average).The low-risk,intermediate-risk and high-risk prostate cancer were 22,29 and 66 cases.Biochemical no evidence of disease (bNED),overall survival and complications were recorded.Results Followed up from 19 to 114 months (84 months in average),33 cases had biochemical recurrence (bNED rate,72％).Twelve patients died,among which 4 patients died of prostate cancer.The overall survival rate was 90％,and the cancer-specific survival rate was 97％.The bNED rates in low-risk,intermediate-risk and high-risk groups were 86％,79％ and 64％,and the difference was significant among the 3groups (P=0.040).The overall survival rates were 100％,90％ and 86％,with no significant difference among the 3 groups (P=0.189).Urinary retention occurred in 11 cases (9％),among which 1 patient had TURP treatment.No serious complications such as rectal fistula occurred.Conclusions The long-term efficacy of brachytherapy in early stage prostate cancer is definite with few complications.With a mean followup of 7 years,the bNED rate was 72％ and the overall survival rate was 90％.Key words: Prostate neoplasms; Brachytherapy; Efficacy; Follow-up studies" @default.
- W3031081258 created "2020-06-05" @default.
- W3031081258 creator A5035203769 @default.
- W3031081258 creator A5057056291 @default.
- W3031081258 creator A5063244087 @default.
- W3031081258 creator A5074389250 @default.
- W3031081258 creator A5074707571 @default.
- W3031081258 creator A5075318877 @default.
- W3031081258 creator A5090650158 @default.
- W3031081258 date "2014-04-15" @default.
- W3031081258 modified "2023-09-26" @default.
- W3031081258 title "Brachytherapy in early stage prostate cancer: an average of 7-year follow-up" @default.
- W3031081258 doi "https://doi.org/10.3760/cma.j.issn.1000-6702.2014.04.010" @default.
- W3031081258 hasPublicationYear "2014" @default.
- W3031081258 type Work @default.
- W3031081258 sameAs 3031081258 @default.
- W3031081258 citedByCount "0" @default.
- W3031081258 crossrefType "journal-article" @default.
- W3031081258 hasAuthorship W3031081258A5035203769 @default.
- W3031081258 hasAuthorship W3031081258A5057056291 @default.
- W3031081258 hasAuthorship W3031081258A5063244087 @default.
- W3031081258 hasAuthorship W3031081258A5074389250 @default.
- W3031081258 hasAuthorship W3031081258A5074707571 @default.
- W3031081258 hasAuthorship W3031081258A5075318877 @default.
- W3031081258 hasAuthorship W3031081258A5090650158 @default.
- W3031081258 hasConcept C121608353 @default.
- W3031081258 hasConcept C126322002 @default.
- W3031081258 hasConcept C126894567 @default.
- W3031081258 hasConcept C141071460 @default.
- W3031081258 hasConcept C146357865 @default.
- W3031081258 hasConcept C151730666 @default.
- W3031081258 hasConcept C2776235491 @default.
- W3031081258 hasConcept C2776283816 @default.
- W3031081258 hasConcept C2777416452 @default.
- W3031081258 hasConcept C2780192828 @default.
- W3031081258 hasConcept C509974204 @default.
- W3031081258 hasConcept C71924100 @default.
- W3031081258 hasConcept C86803240 @default.
- W3031081258 hasConceptScore W3031081258C121608353 @default.
- W3031081258 hasConceptScore W3031081258C126322002 @default.
- W3031081258 hasConceptScore W3031081258C126894567 @default.
- W3031081258 hasConceptScore W3031081258C141071460 @default.
- W3031081258 hasConceptScore W3031081258C146357865 @default.
- W3031081258 hasConceptScore W3031081258C151730666 @default.
- W3031081258 hasConceptScore W3031081258C2776235491 @default.
- W3031081258 hasConceptScore W3031081258C2776283816 @default.
- W3031081258 hasConceptScore W3031081258C2777416452 @default.
- W3031081258 hasConceptScore W3031081258C2780192828 @default.
- W3031081258 hasConceptScore W3031081258C509974204 @default.
- W3031081258 hasConceptScore W3031081258C71924100 @default.
- W3031081258 hasConceptScore W3031081258C86803240 @default.
- W3031081258 hasIssue "04" @default.
- W3031081258 hasLocation W30310812581 @default.
- W3031081258 hasOpenAccess W3031081258 @default.
- W3031081258 hasPrimaryLocation W30310812581 @default.
- W3031081258 hasRelatedWork W1554305871 @default.
- W3031081258 hasRelatedWork W1980995703 @default.
- W3031081258 hasRelatedWork W1995448382 @default.
- W3031081258 hasRelatedWork W2045279552 @default.
- W3031081258 hasRelatedWork W2125478439 @default.
- W3031081258 hasRelatedWork W2127755970 @default.
- W3031081258 hasRelatedWork W2183382634 @default.
- W3031081258 hasRelatedWork W2286234833 @default.
- W3031081258 hasRelatedWork W2405509748 @default.
- W3031081258 hasRelatedWork W2417328572 @default.
- W3031081258 hasRelatedWork W2417455251 @default.
- W3031081258 hasRelatedWork W2419656156 @default.
- W3031081258 hasRelatedWork W2462136144 @default.
- W3031081258 hasRelatedWork W2586277644 @default.
- W3031081258 hasRelatedWork W2763207926 @default.
- W3031081258 hasRelatedWork W2770854901 @default.
- W3031081258 hasRelatedWork W2784078378 @default.
- W3031081258 hasRelatedWork W3029207522 @default.
- W3031081258 hasRelatedWork W3029627276 @default.
- W3031081258 hasRelatedWork W3029689690 @default.
- W3031081258 hasVolume "35" @default.
- W3031081258 isParatext "false" @default.
- W3031081258 isRetracted "false" @default.
- W3031081258 magId "3031081258" @default.
- W3031081258 workType "article" @default.